Atea Pharmaceuticals, Inc.
AVIRNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $333.01M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.87$6.45
- Volume (live)
- -
- Avg. volume (3M)
- 303.83K
Atea Pharmaceuticals (AVIR) Stock Price & Financial Analysis
Atea Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.94 - $4.24 |
|---|---|
| 52-Week High | $6.45 |
| 52-Week Low | $2.87 |
| Open | $4.04 |
| Volume (last close) | 251.09K |
| Average Volume (3M) | 303.83K |
| 50-Day MA | $5.21 |
|---|---|
| 200-Day MA | $4.90 |
| 1-Year Change | +26.96% |
| Market Cap | 333.01M |
|---|---|
| Shares Outstanding | 80.05M |
| Price to Book (P/B) | 1.63 |
| EV/EBITDA | -1.38 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Atea Pharmaceuticals at a Glance
As of the Oct 26, 2026 close, Atea Pharmaceuticals (AVIR) has a market capitalization of $333.01M.
As of its latest reported balance sheet, it holds $76.55M in cash and securities against $424.00K of debt, a net cash position of $76.12M.
Atea Pharmaceuticals does not currently pay a dividend.
The share price is up 27.0% over the past year. At $4.16 (the Oct 26, 2026 close) it sits within its 52-week range of $2.87 to $6.45, below its 200-day moving average of $4.90.
Frequently Asked Questions About Atea Pharmaceuticals
What is the current stock price for AVIR?
As of the Oct 26, 2026 close, AVIR stock trades at $4.16. The 52-week range is $2.87–$6.45, with a day range of $3.94–$4.24.
What is the P/E ratio for AVIR?
The P/E ratio (Price-to-Earnings) for AVIR is shown in the Key Statistics section. This valuation metric helps compare Atea Pharmaceuticals, Inc. to industry peers.
Does AVIR pay dividends?
Atea Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for AVIR?
Analyst ratings and recommendations for AVIR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of AVIR?
As of the Oct 26, 2026 close, Atea Pharmaceuticals's market capitalization is $333.0M, classifying it as a small-cap company. Atea Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.